New consignment of Spikevax vaccine, produced by Moderna company, brought to Moldova

18:06 | 15.02.2022 Category: Social

Chisinau, 15 February /MOLDPRES/ - The National Public Health Agency (ANSP) today received a consignment of 100,800 doses of Spikevax vaccine, produced by the Moderna company. The doses were donated to Moldova through the COVAX mechanism.

According to ANSP data, in 2021, Moldova received 280,800 doses of Spikevax vaccine. The first batch, of 50,400 doses, donated through the COVAX mechanism, was brought to Chisinau in late last November. The second consignment, of 230,400 doses, provided by France for free through the COVAX platform, was received in late December 2021.

The Spikevax vaccine, produced by the Moderna pharmaceutical company, uses the technology based on messenger RNA. This type of vaccine teachers the human body to create the antibodies needed in the fight against the SARS-CoV-2 virus. Clinical studies showed that the vaccine has an efficiency of 94.1 per cent for protection against COVID-19, 14 days following the administering of the first dose.

Photo: ANSP

Any material published on the website of the Public Institution ’’A.I.S. Moldpres’’ (Moldpres News Agency) is intellectual peoperty of the Agency, protected by the copyright. The taking over or/and use of these materials will be made only with the Agency’s agreement and with compulsory reference to source.